
IndraLab
Statements
Tofacitinib inhibits STAT1. 14 / 14
|
14
reach
"Through its ability to inhibit JAK1 activity, tofacitinib is able to block the activation of STAT3 and STAT1 downstream of IL-6 and STAT1 but not STAT4 activation downstream of IL-12 even at a high concentration of the inhibitor (500nM in vitro) [XREF_BIBR] In summary these changes are associated with a reduction in mouse Th1 and Th2 polarization and a reduction in the expression of inflammatory cytokines from both T cells and cells of the innate immune system [XREF_BIBR]."
reach
"They demonstrated that tofacitinib significantly decreased Signal Transducer and Activator of Transcription (STAT) 3, pSTAT1, Nuclear Factor (NF) kappaBp65 and induced Suppressor of Cytokine Signaling (SOCS) 53 and Protein Inhibitor Of Activated STAT (PIAS) 3 expression in the cells and explant cultures."
reach
"Gao et al. [XREF_BIBR] have administered tofacitinib to synovial cells obtained from patients with psoriatic arthritis and found that tofacitinib statistically significant inhibited STAT3 and STAT1, in addition to stimulating suppressor of cytokine signaling 3 (SOCS3) and protein inhibitor of activated STAT3 (PIAS3)."